Recombinant Anti-AR x Anti-DNA Bispecific Antibody (scFv-IgG) (BSSG-012)

Recombinant Anti-AR x Anti-DNA Bispecific Antibody (scFv-IgG) is formed by an IgG and two scFv fragments. The scFvs from an anti-AR antibody variable domain are respectively connected to the N terminus of the anti-DNA IgG heavy chains or light chains to form scFv-(H)IgG or scFv-(L)IgG. It is a type of appended IgGs and has 2+2 antigen-binding valency. This BsAb can enter prostate cancer cells and inhibits androgen receptor function. It is designed for the research of prostate cancer therapy.

Datasheet INQUIRY

Specifications

Targets

AR & DNA

Type

Appended IgGs

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Prostate cancer

Targets

Target 1

Gene ID

367

UniProt ID

P10275

Alternative Names

AR; androgen receptor; KD; AIS; TFM; DHTR; SBMA; HYSP1; NR3C4; SMAX1; HUMARA; dihydrotestosterone receptor; androgen nuclear receptor variant 2; nuclear receptor subfamily 3 group C member 4

Target 2

DNA

Alternative Names

DNA; Deoxyribonucleic acid

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-AR x Anti-DNA Bispecific Antibody (scFv-IgG) (BSSG-012). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-AR x Anti-DNA Bispecific Antibody (scFv-IgG) (CAT#: BSSG-012)

Specifications

Targets

Customer Reviews and Q&As